-24.30 (-1.91%) Dr. Reddy’s Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its formulations facility at Srikakulam in the state of Andhra Pradesh.
USFDA has maintained Official Action Indicated (OAI) status at its API manufacturing plant at Srikakulam.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.